← Scoopfeeds — Intelligent news, curated.
Acadia Pharmaceuticals stock gets $23 price target from Oppenheimer on CHMP reversal
business

Acadia Pharmaceuticals stock gets $23 price target from Oppenheimer on CHMP reversal

Investing.com · Jun 26, 2026, 5:20 PM · Also reported by 3 other sources

Acadia Pharmaceuticals stock gets $23 price target from Oppenheimer on CHMP reversal

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Why Acadia Pharmaceuticals Stock Is Soaring Today Yahoo Finance Prediction: SanDisk Has Rallied Too Far, Too Fast. The Price Target Warns of 20%+ Downside Yahoo Finance Stock Price Prediction: Super Micro Computer Set for 10% Climb After Repricing

More in business

Forbes
World Cup 2026 Has Unleashed A Flood Of American Optimism
Investing.com
Judge orders DOJ to justify dropping Adani criminal case
Investing.com
Hyundai to recall over 96,000 US vehicles over faulty instrument panel display, NHTSA says
Forbes
The Hidden Hero Behind North America’s Number One Cocktail Bar
Investing.com
Alexanders Inc stock hits 52-week high at 271.62 USD
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop